Pulmonary vein remodeling in hypertension: Mechanistic insight into primary prevention of atrial fibrillation

References (2)

1. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a populationbased cohort. The Framingham Heart Study. JAMA 1994; 271: 840-4.
2. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res 2017; 120: 1501-17. [CrossRef] Choisy SC, Arberry LA, Hancox JC, James AF. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts. Hypertension 2007; 49: 498-505. [CrossRef] Iwasaki YK, Yamashita T, Sekiguchi A, Hayami N, Shimizu W. Importance of Pulmonary Vein Preferential Fibrosis for Atrial Fibrillation Promotion in Hypertensive Rat Hearts. Can J Cardiol 2016; 32: 767- 76. [CrossRef] Lau DH, Shipp NJ, Kelly DJ, Thanigaimani S, Neo M, Kuklik P, et al. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PloS One 2013; 8: e72416. [CrossRef] Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015; 386: 154-62. [CrossRef]